Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NeuroInvestment who wrote (765)	1/26/2000 8:11:00 AM
From: Dr. John M. de Castro	Read Replies (1) of 1494

I concur with Dr. Tracy. It is my understanding that patient enrollment is complete in the ADC trial. But, results will not be available until the late Summer at the earliest and maybe not till the Fall. Unfortunately, NTII is not in charge here, the NIH is and they do not have the same pressures to produce as a private company. BTW: Dr. Tracy, thanks for the kind words. But, I know for a fact that you have much to add to teh meagre contributions on this thread. But, you're comments are proprietary and rightly belong to your subscribers. I appreciate greatly the contributions that you do choose to make. For those of you who are not familiar with the Neuroinvestment newsletter, take a look at neuroinvestment.com It is an outstanding, scientifically accurate, tightly reasoned, and well informed newsletter, that I highly recommend. I have participated in Company conference calls with Dr. Tracy and can attest to the esteem with which he is held by the companies and the investment community. He's a class act and that fact has not gone unnoticed. Best regards John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next